Title: Exploring Lipid Modifications in SARS-CoV-2 for Viral Infection
Written on
Chapter 1: Understanding SARS-CoV-2’s Mechanism
The SARS-CoV-2 virus, the central figure of the Covid-19 pandemic, relies heavily on lipid modifications to effectively organize its membrane structures and enhance the functionality of its virulence proteins. Unlike many other viruses, SARS-CoV-2 does not possess lipid-modifying enzymes or the corresponding genes; instead, it entirely depends on the enzymes provided by the host (infected) cells.
In a recent study, a team of cell biologists investigated the extent to which the Spike protein of SARS-CoV-2 undergoes lipid modifications and identified the specific human enzymes, known as “zDHHC-acetyltransferases,” that the virus exploits for this purpose.
The inquiry began when researchers observed that the Spike protein contains ten cysteine amino acids situated in a compact loop right after the segment that anchors it to the membrane. Typically, cysteines located near membranes are prone to lipid attachment, which often has functional implications. The membrane referenced here pertains to the virus’s own membrane when it exists as free infectious particles or to the membranes of the host cells during viral assembly. Notably, the viral membrane is constructed from the lipids of the host cells in which the virus replicates.
SARS-CoV-2’s Spike protein is vital for its infectivity, as it binds to the human ACE2 protein found on the surface of target cells during the initial phase of infection. The research demonstrated that all ten cysteines of the Spike protein are modified, indicating that lipids are attached to them, primarily by one specific DHHC enzyme, which mistakenly identifies the Spike protein as a natural substrate.
Furthermore, the study indicates that the lipid attachment to the Spike protein influences the lipid composition and organization of the viral membranes. Utilizing molecular dynamics simulations, I contributed to the research by demonstrating that lipid attachment alters how the Spike protein partitions within the membrane, potentially even aiding in reshaping it. Experimental results revealed that viral particles produced in test cells lacking the particular DHHC enzyme, and thus having less lipid-modified Spike proteins, exhibited abnormal membrane compositions and a significantly diminished capacity to fuse with host cell membranes. This suggests that lipid modifications of the Spike protein are essential for the virus to achieve full infectivity.
Section 1.1: Implications for Drug Development
This aspect of the study is particularly intriguing, as it suggests that designing a drug to inhibit the specific DHHC enzyme's action on the Spike protein could pave the way for treatments against the viral infection—not only for SARS-CoV-2 but potentially for other viruses that exploit the host's lipid attachment system. The research presented evidence showing that chemicals which interfere with lipid addition to Spike effectively hindered the virus's ability to infect cells. However, these chemicals are not immediately applicable for treating infections, and there is no assurance that they will lead to viable medications. Nonetheless, we have at least pinpointed a potential target for drug development—the initial step in the journey toward creating new clinical treatments, a process often pursued by academic laboratories.
Section 1.2: Visual Insights into Viral Structures
The following figure provides a visual representation of the concepts discussed, zooming in on the membrane of a viral particle rendered in augmented reality through experimental electron tomography:
For additional augmented reality perspectives of viruses, explore this story:
Shots of Viruses in Augmented Reality
Not merely illustrations but actual experimental reconstructions. You can view these models in augmented reality firsthand.
Key Reads
To access the complete technical, peer-reviewed article:
For more information, visit EPFL’s coverage on their news page: